ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Enliven Therapeutics Inc

Enliven Therapeutics Inc (ELVN)

21.68
0.18
(0.84%)
終了 2月15日 6:00AM
21.68
0.00
( 0.00% )
プレマーケット: 9:00PM
高度なチャート

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
21.68
買値
20.80
売値
30.05
出来高
24
0.00 日の範囲 0.00
10.9001 52 週間の範囲 30.03
時価総額
前日終値
21.68
始値
-
最終取引時間
20:48:25
財務取引量
-
VWAP
-
平均取引量 (3 か月)
221,831
発行済株式数
48,859,166
配当利回り
-
PER
-4.31
1 株当たり利益 (EPS)
-1.47
歳入
-
純利益
-71.58M

Enliven Therapeutics Inc について

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer. The Company focuses on addressing existing and emerging unmet needs with a precision oncology approach. The Company is advancin... Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer. The Company focuses on addressing existing and emerging unmet needs with a precision oncology approach. The Company is advancing two parallel lead product candidates, ELVN-001 and ELVN-002, as well as pursuing several additional research stage opportunities. Its first product candidate, ELVN-001, is a potent, highly selective, small molecule kinase inhibitor designed to specifically target the breakpoint cluster region-Abelson (BCR-ABL) gene fusion, the oncogenic driver for patients with chronic myeloid leukemia (CML). Its second product candidate, ELVN-002, is a potent, selective, and irreversible human epidermal growth factor receptor 2 (HER2) inhibitor with activity against various HER2 mutations, including Exon 20 insertion mutations (E20IMs) in non-small cell lung cancer (NSCLC). 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
本社
Wilmington, Delaware, USA
設立
-
Enliven Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ELVN. The last closing price for Enliven Therapeutics was US$21.68. Over the last year, Enliven Therapeutics shares have traded in a share price range of US$ 10.9001 to US$ 30.03.

Enliven Therapeutics currently has 48,859,166 shares in issue. The market capitalisation of Enliven Therapeutics is US$1.06 billion. Enliven Therapeutics has a price to earnings ratio (PE ratio) of -4.31.

ELVN 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.482.264150943421.222.9120.6725757321.64363245CS
4-0.04-0.18416206261521.7223.1820.425195821.7254837CS
12-3.39-13.522138013625.0725.9620.1622183122.52985078CS
26-2.08-8.7542087542123.7630.0320.1623324224.45580398CS
525.2732.114564290116.4130.0310.900126491022.79770004CS
156-2.52-10.413223140524.230.039.820871120.88177367CS
260-2.52-10.413223140524.230.039.820871120.88177367CS

ELVN - Frequently Asked Questions (FAQ)

What is the current Enliven Therapeutics share price?
The current share price of Enliven Therapeutics is US$ 21.68
How many Enliven Therapeutics shares are in issue?
Enliven Therapeutics has 48,859,166 shares in issue
What is the market cap of Enliven Therapeutics?
The market capitalisation of Enliven Therapeutics is USD 1.06B
What is the 1 year trading range for Enliven Therapeutics share price?
Enliven Therapeutics has traded in the range of US$ 10.9001 to US$ 30.03 during the past year
What is the PE ratio of Enliven Therapeutics?
The price to earnings ratio of Enliven Therapeutics is -4.31
What is the reporting currency for Enliven Therapeutics?
Enliven Therapeutics reports financial results in USD
What is the latest annual profit for Enliven Therapeutics?
The latest annual profit of Enliven Therapeutics is USD -71.58M
What is the registered address of Enliven Therapeutics?
The registered address for Enliven Therapeutics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
Which industry sector does Enliven Therapeutics operate in?
Enliven Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
SLDBSolid Biosciences Inc
US$ 7.1282
(76.88%)
26.45M
EFOIEnergy Focus Inc
US$ 2.1204
(64.37%)
17.3M
INTGIntergroup Corporation
US$ 22.80
(61.13%)
6
EDRYEuroDry Ltd
US$ 16.69
(58.95%)
8
HCTIHealthcare Triangle Inc
US$ 0.7466
(55.90%)
29.92M
RSLSReShape Lifesciences Inc
US$ 1.01
(-56.65%)
1.53M
INNVInnovAge Holding Corporation
US$ 1.81
(-46.61%)
1
BPTHBio Path Holdings Inc
US$ 0.40
(-36.83%)
816.31k
KTCCKeyTronic Corporation
US$ 2.01
(-36.79%)
1
DAREDare Bioscience Inc
US$ 2.01
(-33.88%)
41
ADTXAditxt Inc
US$ 0.0832
(18.86%)
183.59M
HCTIHealthcare Triangle Inc
US$ 0.7466
(55.90%)
29.92M
GLYCGlycoMimetics Inc
US$ 0.3621
(24.86%)
29.24M
KWEKWESST Micro Systems Inc
US$ 0.651
(39.40%)
28.75M
SLDBSolid Biosciences Inc
US$ 7.1282
(76.88%)
26.45M

ELVN 財務

財務